Lexicon Pharma (LXRX) Misses Q2 EPS by 4c
Tweet
Share
E-mail
Get Alerts LXRX Hot Sheet
Price: $2.32 --0%
Financial Fact:
Other income (expense), net: 564K
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Other income (expense), net: 564K
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q2 EPS of ($0.22), $0.04 worse than the analyst estimate of ($0.18). Revenue for the quarter came in at $320 thousand versus the consensus estimate of $133.33 thousand.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is Treasury selloff a major issue for stock market bulls?
- INVO Fertility (IVF) Tops Q2 EPS by 105c
- Securitize Corp (SECZ) PT Lowered to $10 at Benchmark as Stock Plummets Post Q2 Earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
